These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2091888)

  • 1. Pharmacokinetics of eltoprazine in healthy subjects.
    van Harten J; Mathlener IS; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):149-58. PubMed ID: 2091888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of eltoprazine in the dog.
    Lammers R; van Harten J
    Drug Metabol Drug Interact; 1990; 8(1-2):141-8. PubMed ID: 2091887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-proportionality of eltoprazine. Pharmacokinetics of single oral doses in healthy subjects.
    de Vries MH; de Koning P; Floot HL; Grahnén A; Eckernäs SA; Raghoebar M; Dahlström B; Ekman L
    Eur J Clin Pharmacol; 1991; 41(5):485-8. PubMed ID: 1761079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of eltoprazine in healthy male subjects after single dose oral and intravenous administration.
    Raghoebar M; Mak M; Cournot A; Pistorius MC; Van Harten J; Roseboom H
    Br J Clin Pharmacol; 1990 Dec; 30(6):879-83. PubMed ID: 2288834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
    Muirhead GJ; Rance DJ; Walker DK; Wastall P
    Br J Clin Pharmacol; 2002; 53 Suppl 1(Suppl 1):13S-20S. PubMed ID: 11879255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 14C-N-N'-dicyclopropyl-methyl-piperazine-dichlorhydrate. 1st Communication: balance of elimination, plasma and blood kinetics, metabolism in rats.
    Tufenkji AE; Campistron G; Malbosc R; Declume C; Dormard Y; Atabakhsh F; Benard P; Houin G
    Arzneimittelforschung; 1993 Mar; 43(3):323-6. PubMed ID: 8489560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolite patterns of eltoprazine in man, dog, rat and rabbit.
    Koster HJ; de Greef L; Klerks F; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):129-39. PubMed ID: 2091886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absolute bioavailability of imatinib (Glivec) orally versus intravenous infusion.
    Peng B; Dutreix C; Mehring G; Hayes MJ; Ben-Am M; Seiberling M; Pokorny R; Capdeville R; Lloyd P
    J Clin Pharmacol; 2004 Feb; 44(2):158-62. PubMed ID: 14747424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition and metabolism of radiolabeled casopitant in humans.
    Pellegatti M; Bordini E; Fizzotti P; Roberts A; Johnson BM
    Drug Metab Dispos; 2009 Aug; 37(8):1635-45. PubMed ID: 19420128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of radioactively labelled eltoprazine in rat and dog.
    de Lange N; Raghoebar M
    Drug Metabol Drug Interact; 1990; 8(1-2):115-27. PubMed ID: 2091885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers.
    Carchman SH; Crowe JT; Wright GJ
    J Clin Pharmacol; 1987 Oct; 27(10):762-7. PubMed ID: 3323255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linear pharmacokinetics of a new inotropic agent.
    Trenque T; Barre J; Lamiable D; Tillement JP
    Arzneimittelforschung; 1994 Apr; 44(4):471-3. PubMed ID: 8010998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sildenafil after intravenous and oral administration in rats: hepatic and intestinal first-pass effects.
    Shin HS; Bae SK; Lee MG
    Int J Pharm; 2006 Aug; 320(1-2):64-70. PubMed ID: 16730145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction.
    Farthing MJ; Alstead EM; Abrams SM; Haug G; Johnston A; Hermann R; Niebch G; Ruus P; Molz KH; Turner P
    Postgrad Med J; 1994 May; 70(823):363-6. PubMed ID: 8016009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and metabolism of a sulphamide NK2 antagonist in rat, dog and human.
    Beaumont K; Harper A; Smith DA; Abel S
    Xenobiotica; 2000 Jun; 30(6):627-42. PubMed ID: 10923864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man.
    Walker DK; Ackland MJ; James GC; Muirhead GJ; Rance DJ; Wastall P; Wright PA
    Xenobiotica; 1999 Mar; 29(3):297-310. PubMed ID: 10219969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous pharmacokinetics and absolute oral bioavailability of dolasetron in healthy volunteers: part 1.
    Dimmitt DC; Choo YS; Martin LA; Arumugham T; Hahne WF; Weir SJ
    Biopharm Drug Dispos; 1999 Jan; 20(1):29-39. PubMed ID: 10086835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90).
    Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW
    Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.